ADAM2 and lung carcinoma: To this end, we have identified antibodies suitable for immunostaining of the three novel CT antigens ADAM2, CALR3 and SAGE1, and characterized the expression of these proteins in normal tissues and the two most common types of human malignancies, breast and lung cancer.